Good morning from OWITH.ai, the podcast that gives you only what's important to hear in the AI and tech world.At the 2026 World Economic Forum in Davos, discussions have shifted from the initial hype around generative AI to more pragmatic conversations about its ROI and practical applications. Business leaders are now concentrating on deriving tangible business benefits from AI, moving from the experimental phase to large-scale implementation. CEOs are leading AI initiatives top-down, driven by the need for measurable impacts on business processes. Leaders like Siemens' Jim Hagemann Snabe advocate for a more directive approach in AI deployment. Industry experts emphasize the necessity of CEO and board sponsorship for successful enterprise AI adoption. Companies are establishing centers of excellence to optimize work processes through AI, with data centralization being crucial.The race among SaaS companies to become the primary interface layer for enterprise AI agents is intensifying, with Workday, Salesforce, Microsoft, and Snowflake competing in this space. Despite concerns about job displacement due to AI, current economic data doesn't yet reflect significant impacts. Discussions also include ethical considerations regarding AI regulation based on human values and potential societal effects of ad-based AI models. Geopolitical implications of AI technology are under scrutiny, with debates over easing U.S. restrictions on AI chip sales to China.OpenAI is preparing to introduce its first consumer device focused on AI-driven interaction in late 2026. Additionally, OpenAI plans to introduce ads at the bottom of ChatGPT's responses for free users and Go subscribers as a new revenue stream despite the high costs of running advanced AI models. Meanwhile, Anthropic's new product, Claude Code, allows users to perform complex tasks without coding, sparking discussions about job displacement and competition among startups.Overall, Davos reflects a maturation in the approach towards AI, prioritizing strategic implementation while addressing economic opportunities and ethical challenges. These discussions set the stage for navigating the evolving landscape of AI in 2026 and beyond.Transitioning from global forums to innovative startups, Formulary, a company supported by Khosla Ventures, has successfully raised an oversubscribed $4.6 million seed round to develop its AI-powered fund management software for private equity and venture capital firms. Alfia Ilicheva founded Formulary after recognizing inefficiencies in private markets due to fragmented and manually compiled data. The company's goal is to automate tedious processes like tracking investments and returns, offering accurate data to investors or limited partners. Formulary aims for a middle ground between high-touch accounting services and pure software solutions by creating tech-enabled services with "bionic accountants." Khosla Ventures led the seed round, joined by Human Ventures and Serena Williams's venture firm. Although fund administration might not be glamorous, it is essential for accurate financial management and communication with investors. Current market solutions are split between service-oriented firms like SS&C and Citco, and software solutions like Carta. Formulary's innovation lies in using AI to scale the service approach effectively. The company plans to deliver most of its product through technology, aiming for margins more akin to a technology firm than a traditional services company. Looking ahead, Formulary envisions features such as drafting letters for limited partners and creating platforms for direct interaction with investors.Shifting gears towards major tech inSupport the show
Thanks for listening! Follow us on Twitter, Instagram and Linkedin